-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明,无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
19,116 Shares in Cutera, Inc. (NASDAQ:CUTR) Bought by Walleye Capital LLC
19,116 Shares in Cutera, Inc. (NASDAQ:CUTR) Bought by Walleye Capital LLC
Walleye Capital LLC bought a new position in shares of Cutera, Inc. (NASDAQ:CUTR – Get Rating) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 19,116 shares of the medical device company's stock, valued at approximately $1,319,000. Walleye Capital LLC owned about 0.11% of Cutera at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in CUTR. Captrust Financial Advisors increased its holdings in Cutera by 592.2% in the first quarter. Captrust Financial Advisors now owns 533 shares of the medical device company's stock valued at $37,000 after buying an additional 456 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Cutera in the first quarter valued at $95,000. Everence Capital Management Inc. purchased a new position in Cutera in the first quarter valued at $218,000. Teacher Retirement System of Texas purchased a new position in Cutera in the first quarter valued at $220,000. Finally, SG Americas Securities LLC purchased a new position in Cutera in the first quarter valued at $233,000.
Get Cutera alerts:Cutera Stock Performance
CUTR opened at $48.89 on Friday. The firm has a market capitalization of $957.27 million, a PE ratio of -13.32 and a beta of 1.84. Cutera, Inc. has a twelve month low of $31.62 and a twelve month high of $74.38. The firm's 50-day moving average price is $46.67 and its 200 day moving average price is $49.29. The company has a current ratio of 4.36, a quick ratio of 3.83 and a debt-to-equity ratio of 12.56.
Cutera (NASDAQ:CUTR – Get Rating) last issued its earnings results on Thursday, August 4th. The medical device company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.23) by ($0.01). Cutera had a negative return on equity of 151.43% and a negative net margin of 27.62%. The firm had revenue of $64.22 million for the quarter, compared to analysts' expectations of $63.42 million. During the same period last year, the firm earned $0.39 earnings per share. Cutera's revenue for the quarter was up 9.6% on a year-over-year basis. As a group, sell-side analysts expect that Cutera, Inc. will post -1.88 EPS for the current fiscal year.Wall Street Analyst Weigh In
A number of research firms have weighed in on CUTR. Piper Sandler cut their price objective on shares of Cutera from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Friday, August 5th. StockNews.com upgraded shares of Cutera to a "sell" rating in a research report on Friday, September 2nd. Maxim Group reiterated a "buy" rating and issued a $80.00 target price on shares of Cutera in a research report on Friday, August 5th. Finally, TheStreet lowered shares of Cutera from a "c-" rating to a "d+" rating in a research report on Thursday, July 7th.
Cutera Profile
(Get Rating)
Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.
Featured Articles
- Get a free copy of the StockNews.com research report on Cutera (CUTR)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It's a Down Week
Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR – Get Rating).
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.
Walleye Capital LLC bought a new position in shares of Cutera, Inc. (NASDAQ:CUTR – Get Rating) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 19,116 shares of the medical device company's stock, valued at approximately $1,319,000. Walleye Capital LLC owned about 0.11% of Cutera at the end of the most recent reporting period.
根据Walleye Capital LLC在提交给美国证券交易委员会(SEC)的最新Form 13F文件中,该公司在第一季度购买了Cutera,Inc.(纳斯达克代码:CUTT-GET Rating)的新股票头寸。该公司购买了19,116股这家医疗设备公司的股票,价值约1,319,000美元。在最近一次报告期结束时,Walleye Capital LLC拥有Cutera约0.11%的股份。
Several other institutional investors have also recently made changes to their positions in CUTR. Captrust Financial Advisors increased its holdings in Cutera by 592.2% in the first quarter. Captrust Financial Advisors now owns 533 shares of the medical device company's stock valued at $37,000 after buying an additional 456 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank purchased a new position in Cutera in the first quarter valued at $95,000. Everence Capital Management Inc. purchased a new position in Cutera in the first quarter valued at $218,000. Teacher Retirement System of Texas purchased a new position in Cutera in the first quarter valued at $220,000. Finally, SG Americas Securities LLC purchased a new position in Cutera in the first quarter valued at $233,000.
其他几家机构投资者最近也改变了他们在Cutr的头寸。CapTrust Financial Advisors在第一季度增持了592.2的Cutera股份。CapTrust Financial Advisors现在拥有533股这家医疗设备公司的股票,价值3.7万美元,上个季度又购买了456股。Zurcher Kantonalbank苏黎世广东银行在第一季度购买了Cutera的新头寸,价值9.5万美元。Everence Capital Management Inc.在第一季度购买了Cutera的一个新头寸,价值21.8万美元。德克萨斯州教师退休系统在第一季度购买了Cutera的一个新职位,价值22万美元。最后,SG America Securities LLC在第一季度购买了Cutera的一个新头寸,价值23.3万美元。
Cutera Stock Performance
Cutera股票表现
CUTR opened at $48.89 on Friday. The firm has a market capitalization of $957.27 million, a PE ratio of -13.32 and a beta of 1.84. Cutera, Inc. has a twelve month low of $31.62 and a twelve month high of $74.38. The firm's 50-day moving average price is $46.67 and its 200 day moving average price is $49.29. The company has a current ratio of 4.36, a quick ratio of 3.83 and a debt-to-equity ratio of 12.56.
Cutr上周五开盘报48.89美元。该公司市值为9.5727亿美元,市盈率为-13.32,贝塔系数为1.84。Cutera,Inc.的12个月低点为31.62美元,12个月高位为74.38美元。该公司的50日移动均线价格为46.67美元,200日移动均线价格为49.29美元。该公司的流动比率为4.36,速动比率为3.83,债务权益比率为12.56。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
A number of research firms have weighed in on CUTR. Piper Sandler cut their price objective on shares of Cutera from $65.00 to $55.00 and set an "overweight" rating for the company in a report on Friday, August 5th. StockNews.com upgraded shares of Cutera to a "sell" rating in a research report on Friday, September 2nd. Maxim Group reiterated a "buy" rating and issued a $80.00 target price on shares of Cutera in a research report on Friday, August 5th. Finally, TheStreet lowered shares of Cutera from a "c-" rating to a "d+" rating in a research report on Thursday, July 7th.
一些研究公司已经对Cutr发表了看法。派珀·桑德勒将Cutera股票的目标价从65.00美元下调至55.00美元,并在8月5日星期五的一份报告中为该公司设定了“增持”评级。在9月2日星期五的一份研究报告中,StockNews.com将Cutera的股票评级上调至“卖出”。Maxim Group在8月5日(星期五)的一份研究报告中重申了对Cutera的评级,并对Cutera的股票发布了80.00美元的目标价。最后,华尔街在7月7日星期四的一份研究报告中将Cutera的股票评级从C-下调至D+。
Cutera Profile
Cutera轮廓
(Get Rating)
(获取评级)
Cutera, Inc, a medical device company, researches, develops, manufactures, markets, and services laser and energy-based aesthetics systems for practitioners worldwide. The company offers Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for deep dermal remodeling; truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; excel V+, a vascular and benign pigmented lesion treatment platform; truSculpt iD, for the non-surgical body sculpting market; and Secret RF, a fractional RF microneedling system for tissue coagulation and hemostasis.
Cutera,Inc.是一家医疗器械公司,研究、开发、制造、营销激光和基于能量的美学系统,并为全球从业者提供服务。该公司推出了Secret PRO,这是一种利用分数二氧化碳进行皮肤表面重塑和射频微针进行深层真皮重塑的设备;truSculpt flex,一种生物电肌肉刺激设备,可以治疗各种健康水平的患者;EXCEL V+,一种血管和良性色素病变治疗平台;truSculpt ID,用于非手术身体造型市场;Secret RF,一种用于组织凝固和止血的分数射频微针系统。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Cutera (CUTR)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- Is There a Cure for What is Ailing Teladoc Stock?
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It's a Down Week
- 免费获取StockNews.com关于Cutera的研究报告(Cutr)
- 第四季度值得考虑的3家银行
- 股市:红海中的三座强国
- 有什么办法可以治愈Teladoc股票的问题吗?
- MarketBeat:回顾一周9/12-9/16
- 没有人告诉这三只股票这是下跌的一周
Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR – Get Rating).
想看看其他对冲基金持有哪些Cutr吗?访问HoldingsChannel.com获取Cutera,Inc.(纳斯达克代码:CUTT-GET Rating)的最新13F备案和内幕交易信息。
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.
接受Cutera Daily的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Cutera和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国,moomoo上的投资产品和服务由Moomoo Financial Inc.提供,一家受美国证券交易委员会(SEC)监管的持牌主体。 Moomoo Financial Inc.是金融业监管局(FINRA)和证券投资者保护公司(SIPC)的成员。
在新加坡,moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供,该公司受新加坡金融管理局(MAS)监管(牌照号码︰CMS101000) ,持有资本市场服务牌照 (CMS) ,持有财务顾问豁免(Exempt Financial Adviser)资质。本内容未经新加坡金融管理局的审查。
在澳大利亚,moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供,该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构(AFSL No. 224663)。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件,这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大,通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供,并受加拿大投资监管机构(CIRO)监管。
在马来西亚,moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供,该公司受马来西亚证券监督委员会(SC)监管(牌照号码︰eCMSL/A0397/2024) ,持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能,分享给你的好友吧